Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale

Background: HIV associated neurocognitive dysfunction (HAND) ranges from asymptomatic neurocognitive impairment (ANI) to mild neurocognitive disorders (MND) to HIV associated dementia (HAD). Cognitive impairment may impact medication adherence which will ultimately affect morbidity and mortality....

Full description

Bibliographic Details
Main Author: Basavaprabhu Achappa
Format: Article
Language:English
Published: Manipal College of Medical Sciences, Pokhara 2014-05-01
Series:Asian Journal of Medical Sciences
Subjects:
Online Access:https://www.nepjol.info/index.php/AJMS/article/view/8724
_version_ 1828332452766023680
author Basavaprabhu Achappa
author_facet Basavaprabhu Achappa
author_sort Basavaprabhu Achappa
collection DOAJ
description Background: HIV associated neurocognitive dysfunction (HAND) ranges from asymptomatic neurocognitive impairment (ANI) to mild neurocognitive disorders (MND) to HIV associated dementia (HAD). Cognitive impairment may impact medication adherence which will ultimately affect morbidity and mortality. Aim: This study was undertaken to evaluate neurocognitive dysfunction among HIV positive patients using the International HIV Dementia scale(IHDS). Materials and Methods: This cross sectional study was conducted in a tertiary care hospital attached to a medical college that caters to a large number of HIV positive patients. The subjects for this study included HIV positive patients belonging to WHO stage 1 or 2. Data collection was done using a pre tested questionnaire. The International HIV Dementia scale(IHDS) was used to assess HAND. Results: Out of the 101 patients studied, 69(68.3%) were males and 32(31.7%) were females. Among these patients, 88 (87.1%) were receiving antiretroviral therapy (ART), 84 (83.2%) were in WHO stage 1. 91 (90.1%) patients had HAND. There were statistically significant differences in the gender and educational level between patients with or without HAND. As age advanced the percentage of patients having HAND also increased. Conclusion: There was high prevalence of HIV associated neurocognitive dysfunction among HIV positive individuals in our study. Also there was an increase in HIV associated neurocognitive dysfunction with increase in age.
first_indexed 2024-04-13T21:05:19Z
format Article
id doaj.art-249fa47db89c4a59bbd05b32a9bd16d5
institution Directory Open Access Journal
issn 2467-9100
2091-0576
language English
last_indexed 2024-04-13T21:05:19Z
publishDate 2014-05-01
publisher Manipal College of Medical Sciences, Pokhara
record_format Article
series Asian Journal of Medical Sciences
spelling doaj.art-249fa47db89c4a59bbd05b32a9bd16d52022-12-22T02:29:59ZengManipal College of Medical Sciences, PokharaAsian Journal of Medical Sciences2467-91002091-05762014-05-01546164https://doi.org/10.3126/ajms.v5i4.8724Neurocognitive dysfunction among HIV positive patients using International HIV dementia scaleBasavaprabhu Achappa 0Associate Professor, Department of Internal Medicine, Kasturba Medical College, Mangalore (affiliated to Manipal University)Background: HIV associated neurocognitive dysfunction (HAND) ranges from asymptomatic neurocognitive impairment (ANI) to mild neurocognitive disorders (MND) to HIV associated dementia (HAD). Cognitive impairment may impact medication adherence which will ultimately affect morbidity and mortality. Aim: This study was undertaken to evaluate neurocognitive dysfunction among HIV positive patients using the International HIV Dementia scale(IHDS). Materials and Methods: This cross sectional study was conducted in a tertiary care hospital attached to a medical college that caters to a large number of HIV positive patients. The subjects for this study included HIV positive patients belonging to WHO stage 1 or 2. Data collection was done using a pre tested questionnaire. The International HIV Dementia scale(IHDS) was used to assess HAND. Results: Out of the 101 patients studied, 69(68.3%) were males and 32(31.7%) were females. Among these patients, 88 (87.1%) were receiving antiretroviral therapy (ART), 84 (83.2%) were in WHO stage 1. 91 (90.1%) patients had HAND. There were statistically significant differences in the gender and educational level between patients with or without HAND. As age advanced the percentage of patients having HAND also increased. Conclusion: There was high prevalence of HIV associated neurocognitive dysfunction among HIV positive individuals in our study. Also there was an increase in HIV associated neurocognitive dysfunction with increase in age.https://www.nepjol.info/index.php/AJMS/article/view/8724hivhiv associated neurocognitive dysfunction (hand)hiv dementia.
spellingShingle Basavaprabhu Achappa
Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale
Asian Journal of Medical Sciences
hiv
hiv associated neurocognitive dysfunction (hand)
hiv dementia.
title Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale
title_full Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale
title_fullStr Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale
title_full_unstemmed Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale
title_short Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale
title_sort neurocognitive dysfunction among hiv positive patients using international hiv dementia scale
topic hiv
hiv associated neurocognitive dysfunction (hand)
hiv dementia.
url https://www.nepjol.info/index.php/AJMS/article/view/8724
work_keys_str_mv AT basavaprabhuachappa neurocognitivedysfunctionamonghivpositivepatientsusinginternationalhivdementiascale